VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 56 filers reported holding VENTYX BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,353,124 | +89.5% | 758,800 | +78.9% | 7.47% | +48.5% |
| Q2 2023 | $13,908,250 | -81.9% | 424,032 | -81.6% | 5.03% | -88.2% |
| Q1 2023 | $77,010,906 | -32.2% | 2,298,833 | -33.6% | 42.68% | +21.3% |
| Q4 2022 | $113,503,765 | -35.1% | 3,461,536 | -30.9% | 35.19% | -13.1% |
| Q3 2022 | $174,953,000 | +185.4% | 5,011,536 | 0.0% | 40.48% | +131.9% |
| Q2 2022 | $61,291,000 | -9.9% | 5,011,536 | 0.0% | 17.45% | +15.8% |
| Q1 2022 | $68,007,000 | -31.7% | 5,011,536 | 0.0% | 15.08% | -15.9% |
| Q4 2021 | $99,529,000 | – | 5,011,536 | – | 17.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |